Health and Medicine

Meet the Future of Medicine: Join Doctors, Scientists and Innovators at the forefront of Longevity We've assembled the world's leading healthspan dream team. They'll spend 2 days with you decoding lifespan science. They'll demystify and explain the breakthroughs in medicine and tech so you can take improve YOUR health and longevity. Join us this March 15-16, 2024 in West Palm Beach, Florida and get answers to your biggest health and age reversal questions. Get your passes now and Meet the Future of Medicine: Workshop with Dr. David Sinclair, Professor of Genetics at Harvard Medical School 5-time New York Times best-selling…

This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real-world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases Time: 7:55 am - 11:45 am Prices: Physicians (MD, DO, MBBS): USD 250.00, RN, NP,…

The ISPPD Biennial Meeting is the premier global scientific event devoted to the exchange, advancement, and dissemination of the latest discoveries in basic science, microbiology, epidemiology, treatment, and prevention of pneumonia and pneumococcal disease. ISPPD provides an unparalleled international forum to bring together scientific, clinical, and public health experts, practitioners, and students to present, discuss, challenge, and learn from the latest work and advancements on pneumococcal disease. Join us for ISPPD-13 in Cape Town, South Africa on 17-20 March 2024! URLs: Tickets: https://go.evvnt.com/1768996-0?pid=154 Website: https://go.evvnt.com/1768996-3?pid=154 Exhibitor: https://go.evvnt.com/1768996-4?pid=154 Inquiries: https://go.evvnt.com/1768996-5?pid=154 Time: 8:00 AM - 7:00 PM Price: General Admission: USD 0.00

With more than 50 interactive lectures and case-based sessions, this program provides a comprehensive update of the most important changes now impacting Nephrology with guidance on how to incorporate these changes into your clinical practice to optimize patient care and improve outcomes. Many practicing nephrologists and physicians find it difficult to keep up with the rapid scientific and technological advances in renal care because medicine is changing at a faster pace than ever before. This live-streaming and fast-paced educational offering is taught by world-renowned experts and Harvard Medical School's leading clinical faculty. The most important updates and advances in the…

At the conclusion of this activity, participants should be able to: -Use contemporary imaging techniques and protocols in thoracic imaging to accurately diagnose, stage and manage diseases -Discuss the treatment of the liver -Outline CT protocols and techniques in abdominal imaging for improved clinical diagnosis of diseases -Utilize advanced CT for cardiothoracic imaging -Develop differential diagnosis that relates to the pertinent imaging and clinically relevant findings for each of the cases covered in this course -Use contemporary imaging techniques and protocols to accurately diagnose, stage and manage diseases and injuries of the musculoskeletal system. -Outline the fundamentals of the latest…

The "11th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems " (PHARMA 2024), which is scheduled to take place as a hybrid event with both online and offline versions at Singapore during March 18–20, 2024, is being organised by Magnus Group with great pleasure in response to the tremendous success of the past 7 editions of the Pharma and Drug Delivery Systems. The congress's theme this year's theme is Decadal Overview of Recent Trends and Innovations Changing the Pharma Industry" and it aims to inform you of the most recent developments in the fields of Pharma and…

The program will highlight the practice dilemmas and key management strategies essential to enhance the attendees' confidence in caring for heart failure patients. Program topics will provide details to ensure patients receive the highest, most-up-to-date quality of care and achieve the best possible outcomes. Learning Objectives -Recognize the spectrum of signs and symptoms suspicious for heart failure -Describe typical diagnostic testing essential for the diagnosis and management of patients with heart failure -Apply appropriate pharmacologic and non-pharmacologic strategies for patients across the spectrum of heart failure -Describe when referral for advanced heart failure therapies is indicated Intended Audience This course…

We invite all participants worldwide to attend “11th International Conference on Gynecology and Obstetrics” scheduled on March 18-19, 2024 at Zurich, Switzerland. The 11th International Conference on Gynecology and Obstetrics brings together a one-of-a-kind and global blend of large and medium pharmaceutical, biotech, and analytic organisations, colleges, and clinical research establishments, making the gathering an ideal stage for sharing involvement, cultivating cross-industry and scholarly collaboration, and assessing developing innovations around the world. We hope to provide an ideal platform for Researchers, Scholars, and Key Speakers to share data and experiences, to empower people with their in-depth knowledge of Women's Health,…

The Innate Killer Summit is returning for the 9th year as the must-attend meeting for the NK community, committed to addressing the critical challenges across all NK-targeted therapeutic types. Join this focused, collaborative forum spanning Preclinical, Clinical Translation and CMC and Process development to brainstorm with industry pioneers on the best approaches to enhance efficacy and persistence as well as reduce the cost of production. Showcasing innovation across biopharma and academia, we have collaborated with MD Anderson, Replay Bio, Pfizer, Glycostem, Senti Bio, XNK Therapeutics, Sanofi, Zelluna Immunotherapy and many more to uncover translational lessons learned in liquid and solid…

Connecting leaders in drug discovery to optimise organ modelling techniques and facilitate advanced applications.

The 7th Antigen-Specific Immune Tolerance Drug Development Summit returns as the definitive, industry-dedicated forum bringing you the latest discoveries, preclinical, proof-of-concept, biomarker, and clinical development on tolerogenic therapies. Immune tolerance approaches have unprecedented potential to not only treat autoimmune diseases but to cure them; resetting the immune system is the most advantageous approach in biopharma's arsenal to trailblaze past standard immunosuppression treatments and create a new era of transformative therapies. With Diamyd's phase III trial for type I diabetes, COUR, Anokion, Imcyse, Takeda, and Selecta's phase II trials all underway, the field is on the precipice of advancing efficacious antigen-specific…

The 6th Edition of International Conference on Materials Science and Engineering is a prestigious event that brings together researchers, scientists, engineers, industry professionals, and academicians from around the world. The 6th Edition of International Conference on Materials Science and Engineering (MATERIALS 2024), will be held in Singapore from March 18-20, 2024, in a hybrid format. Materials Science and Engineering Conference 2024 will focus on the theme of "Shaping Future by Combining Knowledge and Innovations in Material Science." Materials Congress 2024 aims to provide a platform for the exchange of ideas, the fostering of collaborations, and the sharing of cutting-edge research…

The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and continue pipeline progression within a scattered and distributed market, there has never been a better time to know how to navigate unknown waters. Emulating the 2023 success, the Lab Asset and Facility Management in Pharma Europe returns for the second year running. This expert-led summit is solely dedicated to imparting expert knowledge with the goal of…

The 4th TPD Summit Europe returns as Europe's definitive meeting for uniting Targeted Protein Degradation professionals within Europe and across the globe to explore novel degrader development with new E3 ligase/ligand discovery, overcome safety concerns in PROTACs, and rationally discover molecular glues to deliver clinically approved degraders to high-value targets and patients in need. Across 3-days, our speaker faculty of 35+ world-class TPD specialists will cover end-to-end degrader drug development from novel hit finding, validation, and lead optimisation in our discovery track, to assessing DMPK profiles, measuring efficacy and dose escalation for clinical candidates in our preclinical/clinical track. Join a…

Advance More Personalized Therapies for Rare and Common Kidney Diseases The surge of clinical breakthroughs in SGLT2s, GLP-1s and ERAs for CKD, significant advancements to strengthen proteinuria and GFR slope as surrogates for long-term outcomes, and a wave of promising new targets in development, has truly lit the fuse on decades of innovative kidney research. Bringing together 200+ biopharma stakeholders, from scientific research to clinical development and outcomes, across three days of concentrated discussion, the 6th CKD Drug Development Summit is the definitive forum for KOLs, industry experts, and regulators to concentrate kidney innovation onto the next generation of drug…

Determining MoA and Satisfying Regulatory Requirements In the dynamic cell therapy landscape, the challenge of potency assay development looms large, as exemplified by clinical holds experienced by Mesoblast and Verve Therapeutics in recent years. With unclear licensing standards and the surge in cell therapy products advancing through phase development, linking mechanisms of action to potency assays scientifically has become a pressing concern. At the 3rd Cell Therapy Potency Assay Summit, we bring together over 120 analytical, quality control, and regulatory experts to address these pressing concerns. Our goal is to collaboratively design more effective potency assays that not only streamline…

Not that much time has passed since our last summit. But a lot has changed. From 2023 to 2024, the industry has made unequivocal advances, from tangible progress using artificial intelligence to robust biomarker development, permitting precise prognosis, astute stratification, and meticulous patient monitoring. Unsurprisingly, this is reflected by countless recent approvals, IND filings, and new companies emerging out of stealth-mode. In this context, the Precision Medicine in Inflammatory Bowel Disease Summit is returning for the second year, as the most comprehensive, ultra-specialized meeting. Uniting over 100 precision medicine in IBD experts, this summit will explore mind-blowing development that will…

Following the increasing interest in access to investigational medicines from patients, the harmonization of guidance and research on the value of expanded access programs witnesses a critical rise. Back in Boston as the only industry forum defining global regulations for EAP and your definitive networking opportunity to connect with managed access teams from other leading and new companies that are immersing themselves in this evolving field of opportunity and life-changing support. Reunite with 120+ industry experts setting up and leading EAPs at the 4th Operationalize Expanded Access Programs Summit and gain practical take aways on how to construct a reliable…

Accelerate Your Insight of Mechanisms of Action, Cellular Pathways and Endosomal Escape to Gain Access to Tumor and Cell-Specific Targets Step into the 2nd Targeted Intracellular Delivery Summit, a thrilling exploration of cutting-edge advancements in drug delivery. This year, we redefine possibilities, venturing beyond traditional boundaries with a focus on cellular biology and intracellular mechanisms. Optimize drug delivery, overcome endosomal challenges, and expand therapies beyond the liver with in-depth case studies and a Pre-Conference Workshop Day. Gain insights into targeted cell interventions for cancer and autoimmune diseases, re-thinking innovative delivery platforms and strategies for cargo delivery into novel targets. Engage…

The 4th Wet AMD and Diabetic Eye Disease Drug Development Summit is returning to Boston this March to unite 70+ industry-based retinal vascular experts from the likes of Bayer, Boehringer Ingelheim, Genentech, Novartis and OcuTerra, at the only industry-dedicated forum to transform the potential of treatment of chronic, sight-threatening retinal vascular diseases to improve patient outcomes. Hear fresh perspectives from the new companies speaking at the 2024 meeting including Aviceda Therapeutics, Bayer, Boehringer Ingelheim, OcuTerra, Novartis, Genentech, and Adverum Biotechnologies and discover robust new content focusing on industry-specific topics such as new targets, in vivo and in vitro models, retinal…